While the molecular mechanism by which HSF2 suppresses prostate cancer development remains to be established, a gene expression profiling indicated that HSF2 modulates GTPase activity, cell–cell adhesion, and actin cytoskeleton dynamics, all of which have altered expression in cancer [88]. Here, HSF2 is linked to prostate cancer.